Skip to main content
Top
Published in: Child's Nervous System 6/2021

01-06-2021 | Subdural Hematoma | Case Report

Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma

Authors: William A. Lambert, Joseph A. DiGiuseppe, Tatiana Lara-Ospina, Markus J. Bookland, Jonathan E. Martin, David S. Hersh

Published in: Child's Nervous System | Issue 6/2021

Login to get access

Abstract

Background

Juvenile myelomonocytic leukemia (JMML) is a rare childhood hematopoietic disorder typically presenting with hepatosplenomegaly, lymphadenopathy, pallor, fever, and cutaneous findings. The authors report the first case, to our knowledge, of JMML presenting in a pediatric patient with a subdural hematoma.

Case description

A 7-month old male with recurrent respiratory infections and a low-grade fever presented with a full fontanelle and an increasing head circumference and was found to have chronic bilateral subdural collections. Abusive head trauma, infectious, and coagulopathy workups were unremarkable, and the patient underwent bilateral burr holes for evacuation of the subdural collections. The postoperative course was complicated by the development of thrombocytopenia, anemia, and an acute subdural hemorrhage which required evacuation. Cytologic analysis of the subdural fluid demonstrated atypical cells, which prompted flow cytometric analysis, a bone marrow biopsy, and ultimately a diagnosis of JMML. Following chemotherapy, the patient’s counts improved, and he subsequently underwent a hematopoietic stem cell transplant.

Conclusion

Subdural collections may rarely represent the first presenting sign of hematologic malignancies. In patients with a history of recurrent infections and a negative workup for abusive head trauma, clinicians should include neoplastic etiologies in the differential for chronic subdural collections and have a low threshold for fluid analysis.
Literature
3.
go back to reference Board, P. D. Q. P. T. E (2002) Childhood acute myeloid leukemia/other myeloid malignancies treatment (PDQ®): health professional version. In: PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda Board, P. D. Q. P. T. E (2002) Childhood acute myeloid leukemia/other myeloid malignancies treatment (PDQ®): health professional version. In: PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda
6.
7.
go back to reference Comănescu A, Roşca E, Bota M, Ninulescu G (2008) Chronic subdural hematoma in a patient with acute myeloid leukemia and dural metastatic infiltration. Romanian J Morphol Embryol 49(2):259–262 Comănescu A, Roşca E, Bota M, Ninulescu G (2008) Chronic subdural hematoma in a patient with acute myeloid leukemia and dural metastatic infiltration. Romanian J Morphol Embryol 49(2):259–262
8.
go back to reference Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C (2015) Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood 125(14):2311–2313. https://doi.org/10.1182/blood-2015-01-619734CrossRefPubMed Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C (2015) Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood 125(14):2311–2313. https://​doi.​org/​10.​1182/​blood-2015-01-619734CrossRefPubMed
11.
go back to reference Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF (1996) Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 88(7):2634–2639CrossRef Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF (1996) Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 88(7):2634–2639CrossRef
13.
go back to reference Kitano A, Yamamoto K, Nagao T, Yoshida M, Kurosu T, Arai A, Miki T, Murakami N, Miura O (2005) Successful treatment with drainage of hematoma and chemotherapy in a case of Burkitt leukemia presenting with subdural hematoma. Rinsho Ketsueki 46(4):278–280PubMed Kitano A, Yamamoto K, Nagao T, Yoshida M, Kurosu T, Arai A, Miki T, Murakami N, Miura O (2005) Successful treatment with drainage of hematoma and chemotherapy in a case of Burkitt leukemia presenting with subdural hematoma. Rinsho Ketsueki 46(4):278–280PubMed
22.
go back to reference Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korthof E, van Wering E, Zimmermann M (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89(10):3534–3543PubMed Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korthof E, van Wering E, Zimmermann M (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89(10):3534–3543PubMed
23.
go back to reference Olk-Batz C, Poetsch AR, Nöllke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, Starý J, Bergstraesser E, de Moerloose B, Trebo M, van den Heuvel-Eibrink MM, Wojcik D, Locatelli F, Plass C, Niemeyer CM, Flotho C, the European Working Group of Myelodysplastic Syndromes in Childhood (EWOG-MDS) (2011) Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 117(18):4871–4880. https://doi.org/10.1182/blood-2010-08-298968CrossRefPubMed Olk-Batz C, Poetsch AR, Nöllke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, Starý J, Bergstraesser E, de Moerloose B, Trebo M, van den Heuvel-Eibrink MM, Wojcik D, Locatelli F, Plass C, Niemeyer CM, Flotho C, the European Working Group of Myelodysplastic Syndromes in Childhood (EWOG-MDS) (2011) Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 117(18):4871–4880. https://​doi.​org/​10.​1182/​blood-2010-08-298968CrossRefPubMed
29.
go back to reference Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S (2013) Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 45(8):937–941. https://doi.org/10.1038/ng.2698CrossRefPubMed Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S (2013) Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 45(8):937–941. https://​doi.​org/​10.​1038/​ng.​2698CrossRefPubMed
Metadata
Title
Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma
Authors
William A. Lambert
Joseph A. DiGiuseppe
Tatiana Lara-Ospina
Markus J. Bookland
Jonathan E. Martin
David S. Hersh
Publication date
01-06-2021
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 6/2021
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-020-05013-7

Other articles of this Issue 6/2021

Child's Nervous System 6/2021 Go to the issue